Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
---|
03/13/2008 | WO2008012532A3 : pyridine-3-carboxamide compounds and their use for inhibiting 11-beta-hydroxysteroid dehydrogenase |
03/13/2008 | WO2008008718A3 Cyclopentane derivatives as antiglaucoma agents |
03/13/2008 | WO2007146376A3 Substituted 3-cyanopyridines as protein kinase inhibitors |
03/13/2008 | WO2007123939A8 Novel arylamino n-heteraryls as mek inhibitors |
03/13/2008 | WO2007112299A3 Enzymatic preparation of (s) amino acid from (r,s) amino acid or from keto acid |
03/13/2008 | WO2007107311A3 Organic sulphinic acid derivatives |
03/13/2008 | US20080064731 Remedy for chronic disease |
03/13/2008 | US20080064730 Insecticide, nematocides and for arachnids |
03/13/2008 | US20080064729 Phenethylamide derivatives with kinase inhibitory activity |
03/13/2008 | US20080064728 Heterocyclic Compounds Useful as Dpp-Iv Inhibitors |
03/13/2008 | US20080064717 Type 2 diabetes, obesity, elevated plasma triglycerides, metabolic syndrome, non-alcoholic steatohepatitis, and non-alcoholic fatty liver disease; N-(3-chlorophenyl)-N'-(4'-{(R)-hydroxy[(1R,2R)-2-(hydroxymethyl)cyclopentyl]methyl}-1,1'-biphenyl-4-yl)urea |
03/13/2008 | US20080064690 Neuropathic or inflammatory pain relief; inhibiting ion flux through channel including PN3 subunit; potency |
03/13/2008 | US20080064687 Vanilloid receptor modulators; analgesic, antiinflammatory and antiulcer effects; such as 1-(1H-indol-5-ylmethyl)-3-phenethylthiourea |
03/13/2008 | US20080064662 Agonists having a biphenyl moiety in combination with an amide linkage at the core of the structure enhances selectivity for S1P1 receptor without causing hypotension or bradycardia; transplant rejection, autoimmune diseases; 2-Amino-N-[4-(biphenyl-4-yloxy)-phenyl]3-hydroxy-2-methyl-propionamide |
03/13/2008 | US20080064661 Dihydroxyl compounds and compositions for cholesterol management and related uses |
03/13/2008 | US20080061684 Metal Complex Compound and Organic Electroluminescent Element Using the Same |
03/13/2008 | CA2662852A1 Heteroaromatic compounds having sphingosine-1-phosphate (s1p) receptor agonist and/or antagonist biological activity |
03/13/2008 | CA2662850A1 Heteroaromatic compounds having sphingosine-1-phosphate (s1p) receptor agonist biological activity |
03/13/2008 | CA2662728A1 Substituted bipyridine derivatives and their use |
03/13/2008 | CA2662091A1 N-biaryl (hetero) arylsulphonamide derivatives useful in the treatment of diseases mediated by lymphocytes interactions |
03/13/2008 | CA2660757A1 Insecticidal n-substituted (heteroaryl)alkyl sulfilimines |
03/12/2008 | EP1897870A1 Pharmaceutical composition comprising 2-pyridone derivative as active ingredient |
03/12/2008 | EP1897541A2 Hypoglycemic agent |
03/12/2008 | EP1896417A1 Linear urea mimics antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
03/12/2008 | EP1896416A1 Substituted heterocycles, their use as medicament, and pharmaceutical preparations comprising them |
03/12/2008 | EP1896396A1 Anthranilic acid derivatives |
03/12/2008 | EP1896394A1 Substituted enaminones as nicotinic acetylcholine receptor modulators |
03/12/2008 | EP1896082A2 Conjugates having a degradable linkage and polymeric reagents useful in preparing such conjugates |
03/12/2008 | EP1706382B1 Method for stabilizing 4-halogenpyridines with secondary and/or tertiary amines |
03/12/2008 | EP1656405B1 Novel catalysts for selective isocyanate dimerisation |
03/12/2008 | EP1613596B1 N-[(piperazinyl)hetaryl]arylsulfonamide compounds with affinity for the dopamine d3 receptor |
03/12/2008 | EP1539693B1 Cannabinoid receptor agonists |
03/12/2008 | CN101142326A Methods of using dyes in association with nucleic acid staining or detection and associated technology |
03/12/2008 | CN101142285A Reactive azo dyes, methods for the production thereof and their use |
03/12/2008 | CN101142212A 2-phenoxy-n-(1,3,4-thiadizol-2-yl)pyridin-3-amine derivatives and related compounds as p2y1 receptor inhibitors for the treatment of thromboembolic disorders |
03/12/2008 | CN101142190A Nicotinanilides method for production thereof and agents comprising the same for prevention of fungal pests |
03/12/2008 | CN101142189A 2-pyridine derivatives as inhibitors of neutrophile elastase |
03/12/2008 | CN101142188A 2-pyridine derivatives as inhibitors of neutrophile elastase |
03/12/2008 | CN101142187A 离子型有机化合物 Ionic organic compounds |
03/12/2008 | CN101142172A Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
03/12/2008 | CN101141878A Biphenyl-n-(4-pyridyl)methylsulfonamides |
03/12/2008 | CN101139318A Method for producing low-residual novel weedicide clopyralid |
03/12/2008 | CN101139267A White black falsehellebore alcohol derivative, analogue and preparation method and use thereof |
03/12/2008 | CN100374516C Printing process using specified azo compounds |
03/12/2008 | CN100374448C Diene silicoxyane linking disbenzocyclobutylene monomer and process for preparing prepolymer |
03/12/2008 | CN100374425C Aryl and heteroaryl urea CHK1 inhibitors for use as radiosensitizers and chamosensitizers |
03/12/2008 | CN100374416C P-(sulfonyl)-aryl and heteroaryls amines |
03/11/2008 | US7342131 Levodopa prodrugs, and compositions and uses thereof |
03/11/2008 | US7342127 Substituted anilide ligands for the thyroid receptor |
03/11/2008 | US7342116 Process for producing heterocyclic aldehyde |
03/11/2008 | US7342115 Binding antagonist and arylpyridine for antiinflammatory agents, cardiovascular disorders and antagonist or agonist and for immunology |
03/11/2008 | US7342020 Effective against MMP 9 and 13; arthritis, atherosclerosis; synthesis |
03/11/2008 | US7342013 Benzamides and related inhibitors of factor Xa |
03/11/2008 | US7341607 Yellow anionic disazo dyes |
03/11/2008 | CA2310664C Substituted 2-aminoacetamides and the use thereof |
03/11/2008 | CA2274954C Sulfonamide and carboxamide derivatives and drugs containing the same as the active ingredient |
03/11/2008 | CA2192764C Integrin receptor antagonists |
03/06/2008 | WO2008027073A1 Insecticidal n-substituted (heteroaryl)cycloalkyl sulfoximines |
03/06/2008 | WO2008026577A1 Method for producing phenoxypyridine derivative |
03/06/2008 | WO2008026563A1 Hydrazine amide derivative |
03/06/2008 | WO2008025820A1 Aminopyridine derivates as kinase inhibitors |
03/06/2008 | WO2008025694A1 Inhibitors for glyt-1 |
03/06/2008 | WO2008009360A3 N'-cyano-n-alkyl halide imide amide derivatives |
03/06/2008 | WO2007149829A3 Therapeutic compounds |
03/06/2008 | WO2007145835A3 Benzamide derivatives as modulators of 11beta-hsd1 for treating diabetes and obesity |
03/06/2008 | WO2007131201A3 Compounds and compositions as hedgehog pathway modulators |
03/06/2008 | WO2007126733A3 Styrylpyridine derivatives and their use for binding and imaging amyloid plaques |
03/06/2008 | US20080058546 Methods for Synthesis of Acyloxyalkyl Derivatives of GABA Analogs |
03/06/2008 | US20080058543 Process for making chiral 1,4-disubstituted piperazines |
03/06/2008 | US20080058528 Synthesis of (2S,5R)-5-ethynyl-1-{N-(4-methyl-1-(4-carboxy-pyridin-2-yl)piperidin-4-yl)glycyl}pyrrolidine-2-carbonitrile |
03/06/2008 | US20080058522 Process For The Preparation Of Enantiomerically Enriched Beta Amino Acid Derivatives |
03/06/2008 | US20080058521 Processes for the preparation of compounds |
03/06/2008 | US20080058391 Novel compounds |
03/06/2008 | US20080058383 Such as 2-methyl-2-(4-nitro-3-trifluoromethyl-phenylamino)-propan-1-ol; prostate cancer; cardiovascular disorders; psychological disorders |
03/06/2008 | US20080058382 Polyamine compounds |
03/06/2008 | US20080058334 Dermatological or oncological disorders; N-(4-fluorophenyl)-N'-[4-[1-(1H-imidazol-1-yl)-2-methylpropyl]phenyl]urea for example |
03/06/2008 | US20080058333 Carbamates such as (1-benzylcyclohexyl)methyl(1S)-5-[(4-morpholinylcarbonyl)amino]-1-(oxo([(1R)-1-phenylethyl]amino)acetyl)pentylcarbamate; osteoporosis |
03/06/2008 | US20080058331 Inhibitors for GlyT-1 |
03/06/2008 | US20080058323 Therapy of vascular system diseases |
03/06/2008 | US20080058314 Novel dicarboxylic acid derivatives with pharmaceutical properties |
03/06/2008 | US20080058290 Substituted Phenoxy-and Phenylthio-Derivatives for Treating Proliferative Disorders |
03/06/2008 | US20080054223 Light Emitting Complex Salts |
03/06/2008 | CA2661863A1 Inhibitors for glyt-1 |
03/06/2008 | CA2661702A1 Method for producing phenoxypyridine derivative |
03/06/2008 | CA2661480A1 Insecticidal n-substituted (heteroaryl)cycloalkyl sulfoximines |
03/05/2008 | EP1894917A1 Aryloxy- and arylthioxyacetophenone-type compounds for the treatment of cancer |
03/05/2008 | EP1893609A1 N-(pyridin-2-yl)-sulfonamide derivatives |
03/05/2008 | EP1893601A1 Thrombin inhibiting 2-oxo-1, 2, 5, 6-tetrahydropyridine derivatives |
03/05/2008 | EP1893597A2 Ampa receptor potentiators |
03/05/2008 | EP1893579A1 1-hydroxycycloalkanecarboxamide derivatives as bradykinin antagonists |
03/05/2008 | EP1893567A1 Benzanilides with insecticidal activity |
03/05/2008 | EP1893566A1 Cyclohexanesulfonyl derivatives as glyt1 inhibitors to treat schizophrenia |
03/05/2008 | EP1893562A1 Reversible inhibitors of monoamine oxidase a and b |
03/05/2008 | EP1893245A2 Radiolabeled-pegylation of ligands for use as imaging agents |
03/05/2008 | EP1732541A4 Cyclic compounds |
03/05/2008 | EP1641800B1 Pyrazolopyrimidines |
03/05/2008 | EP1045836B1 Pyridones as src family sh2 domain inhibitors |
03/05/2008 | CN101137643A Novel pyridine compounds |
03/05/2008 | CN101137624A Compounds for inflammation and immune-related uses |
03/05/2008 | CN101137616A Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |